Thermo Fisher officer proposes $2.9M share sale

Available on EDGAR 11/13/2026 - 10:11 AM EST Accepted by SEC EDGAR 11/13/2026 - 10:10 AM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Thermo Fisher Scientific Inc. (TMO) officer Gianluca Pettiti reported a proposed sale of 4,133 common shares, with an approximate sale date of November 13, 2026 and an aggregate market value of $2,898,968.86. A 3,733-share stock-option exercise for cash is listed with an acquisition date of November 13, 2026. The reported sales history also includes 4,133 common shares sold on August 31, 2026, for gross proceeds of $2,539,232.54. The reported date of plan adoption or giving of instruction, if relying on Rule 10b5-1, is June 2, 2026.

Key Figures

Proposed sale: 4,133 common shares Aggregate market value: $2,898,968.86 Stock-option exercise: 3,733 shares +4 more

7 metrics

Proposed sale 4,133 common shares Approximate sale date November 13, 2026.

Aggregate market value $2,898,968.86 For the 4,133 common shares listed for sale.

Stock-option exercise 3,733 shares Acquisition date November 13, 2026; payment stated as cash.

Prior shares sold 4,133 common shares Sold August 31, 2026, during the reported prior three months.

Gross proceeds $2,539,232.54 Proceeds from the August 31, 2026 sale.

Shares outstanding 370,515,868 shares Common shares outstanding, as listed in the issuer information.

Plan adoption or instruction date June 2, 2026 Date listed if relying on Rule 10b5-1.

Key Terms

Rule 10b5-1, Restricted Stock Vesting, Stock Option Exercise

3 terms

Rule 10b5-1 regulatory

"if relying on Rule 10b5-1"

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

Restricted Stock Vesting financial

"Nature of Acquisition Transaction: Restricted Stock Vesting"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

Stock Option Exercise financial

"Nature of Acquisition Transaction: Stock Option Exercise"

A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many TMO shares did officer Gianluca Pettiti propose to sell?

The proposed sale is for 4,133 common shares, with an approximate sale date of November 13, 2026 and an aggregate market value of $2,898,968.86.

How many shares did Gianluca Pettiti sell in the prior three months?

The reported sales history includes 4,133 common shares sold on August 31, 2026, for gross proceeds of $2,539,232.54.

What Rule 10b5-1 plan date is listed for Gianluca Pettiti?

June 2, 2026 is listed as the date of plan adoption or giving of instruction, if relying on Rule 10b5-1.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001844600
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	THERMO FISHER SCIENTIFIC INC.
SEC File Number	001-08002
Address of Issuer	168 THIRD AVENUE WALTHAM MASSACHUSETTS 02451
Phone	7816221000
Name of Person for Whose Account the Securities are To Be Sold	Pettiti Gianluca
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	4133	2898968.86	370515868	11/13/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/05/2022	Restricted Stock Vesting	Issuer			69	05/05/2022	Compensation
Common	08/26/2022	Restricted Stock Vesting	Issuer			112	08/26/2022	Compensation
Common	02/23/2023	Restricted Stock Vesting	Issuer			52	02/23/2023	Compensation
Common	02/23/2024	Restricted Stock Vesting	Issuer			167	02/23/2024	Compensation
Common	11/13/2026	Stock Option Exercise	Issuer			3733	11/13/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Gianluca Pettiti 168 Third Avenue Waltham MA 02451	Common	08/31/2026	4133	2539232.54

144: Remarks and Signature

Remarks
Date of Notice	11/13/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/02/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Daniel Tucci, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Gianluca Pettiti
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)